Characteristics of patients with CLL
| CLL no. . | Sex . | ZAP-70, % positive . | CD38, % positive . | Age at diagnosis, y . | Survival after diagnosis, mo* . |
|---|---|---|---|---|---|
| 169 | M | 0.5 | 5.1 | 34 | > 153 |
| 255 | M | 20.9 | 2.4 | 57 | > 202 |
| 141 | M | 35.5 | 88.4 | 76 | 99 |
| 260 | F | 16.0 | 33.2 | 69 | 163 |
| 376 | F | ND | ND | 76 | > 166 |
| 415 | M | ND | 99.4 | 60 | > 85 |
| 562 | M | 32.1 | 70.6 | 49 | 75 |
| 282 | M | ND | ND | 61 | > 115 |
| 412 | M | ND | 15.8 | 53 | > 175 |
| 183 | M | 15.7 | 7.3 | 63 | > 145 |
| 240 | F | 13.4 | 69.7 | — | — |
| 342 | F | 1.0 | 2.2 | 56 | > 234 |
| 154 | M | 15.5 | 24.9 | 66 | 59 |
| 270 | M | 94.0 | 76.4 | 55 | > 163 |
| 340 | F | ND | ND | 41 | 95 |
| 360 | M | ND | 31.4 | 57 | > 117 |
| 068 | M | 52.6 | 45.9 | 65 | 151 |
| 258 | M | 40.7 | 3.0 | 65 | 99 |
| 114 | M | ND | ND | 59 | 53 |
| 657 | M | 26.3 | 84.5 | 62 | 53 |
| 845 | M | 42.5 | 96.7 | 75 | > 41 |
| 014 | M | 98.1 | 98.0 | 59 | 145 |
| 246 | M | 11.5 | 94.2 | 75 | 20 |
| 355 | M | 11.7 | 22.4 | 65 | 118 |
| 366 | M | ND | ND | 73 | 42 |
| DO13 | F | ND | ND | — | — |
| CLL no. . | Sex . | ZAP-70, % positive . | CD38, % positive . | Age at diagnosis, y . | Survival after diagnosis, mo* . |
|---|---|---|---|---|---|
| 169 | M | 0.5 | 5.1 | 34 | > 153 |
| 255 | M | 20.9 | 2.4 | 57 | > 202 |
| 141 | M | 35.5 | 88.4 | 76 | 99 |
| 260 | F | 16.0 | 33.2 | 69 | 163 |
| 376 | F | ND | ND | 76 | > 166 |
| 415 | M | ND | 99.4 | 60 | > 85 |
| 562 | M | 32.1 | 70.6 | 49 | 75 |
| 282 | M | ND | ND | 61 | > 115 |
| 412 | M | ND | 15.8 | 53 | > 175 |
| 183 | M | 15.7 | 7.3 | 63 | > 145 |
| 240 | F | 13.4 | 69.7 | — | — |
| 342 | F | 1.0 | 2.2 | 56 | > 234 |
| 154 | M | 15.5 | 24.9 | 66 | 59 |
| 270 | M | 94.0 | 76.4 | 55 | > 163 |
| 340 | F | ND | ND | 41 | 95 |
| 360 | M | ND | 31.4 | 57 | > 117 |
| 068 | M | 52.6 | 45.9 | 65 | 151 |
| 258 | M | 40.7 | 3.0 | 65 | 99 |
| 114 | M | ND | ND | 59 | 53 |
| 657 | M | 26.3 | 84.5 | 62 | 53 |
| 845 | M | 42.5 | 96.7 | 75 | > 41 |
| 014 | M | 98.1 | 98.0 | 59 | 145 |
| 246 | M | 11.5 | 94.2 | 75 | 20 |
| 355 | M | 11.7 | 22.4 | 65 | 118 |
| 366 | M | ND | ND | 73 | 42 |
| DO13 | F | ND | ND | — | — |
M indicates male; F, female; ND, not determined; and —, not known.
> indicates patient is still alive as of May 1, 2009.